Approved Study Database
| Ref. No. | Scientific Title | Principal investigator |
|---|---|---|
| 2022.645 | To linguistically and psychometrically validate the Hong Kong Chinese version of the BPH 3-item questionnaire | Prof. NG Chi Fai |
| 2022.301 | A study to evaluate patient and physician benefit/ risk preferences for treatment of metastatic prostate cancer (mPC) in Hong Kong: a discrete choice experiment |
Prof NG Chi Fai 吳志輝 |
| 2020.603 | To investigate the role of gut microbiome in androgen deprivation therapy related metabolic changes in prostate cancer patients |
Prof. NG Chi Fai 吳志輝 |
| 2022.182 | A Phase 2 Open-label Extension Study for Subjects with Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study |
Prof. NG Chi Fai 吳志輝 |
| 2021.484 | Randomized, Open-label, Phase 3 Study of Acapatamab vs Standard of Care in Metastatic Castration-resistant Prostate Cancer (CAPTIVATE) |
Prof. NG Chi Fai 吳志輝 |
| 2021.675 | Development of luminescent nanobiosensor for bladder cancer miRNA detection |
Prof. NG Chi Fai 吳志輝 |
| 2022.244 | The use of temporarily implanted nitinol device (iTind) system in Chinese male patients with lower urinary tract symptom secondary to benign prostate enlargement |
Prof. NG Chi Fai 吳志輝 |
| 2018.276 | A prospective randomized study to investigate the effect of extracorporeal shockwave lithotripsy on blood pressure control in patients with hypertension – a pilot study |
Prof. NG Chi Fai 吳志輝 |
| 2019.491 | Patient Preference of Apalutamide versus Enzalutamide in Patients with Recurrent or Metastatic Hormone-Sensitive Prostate Cancer: An Open-label, Randomized, Cross-Over Trial. (version 1.0) |
Prof. NG Chi Fai 吳志輝 |
| 2018.280 | A cross sectional study to assess the effect of androgen deprivation therapy on Gut and Urinary Microbiota in patients with prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2019.166 | A Phase 3 Randomized Open Label Study to Compare NKTR-214 Combined with Nivolumab to the Investigator's Choice of Sunitinib or Cabozantinib in Patients with Previously Untreated Advanced Renal Cell Carcinoma |
Prof. NG Chi Fai 吳志輝 |
| 2020.454 | A Phase 4, randomized, open-label, multicenter efficacy and safety study of standard dose of radium-223 dichloride vs. standard doses of androgen receptor pathway inhibitor (ARPI) in patients with bone dominant metastatic castration resistant prostate cancer (mCRPC) progressing on/after one line of ARPI |
Prof. NG Chi Fai 吳志輝 |
| 2020.050 | To evaluate the performance of a urine spermine measuring device in predicting prostate biopsy result |
Prof. NG Chi Fai 吳志輝 |
| 2019.534 | To investigate the effect of central arterial stiffness on the progression of male bladder dysfunction, nocturia and lower urinary tract symptoms |
Prof. NG Chi Fai 吳志輝 |
| 2018.541 | SIMCAP (Surgery in Metastatic Carcinoma of Prostate): Phase 2.5 multi-institution randomized prospective clinical trial evaluating the impact of cytoreductive radical prostatectomy combined with best systemic therapy on oncologic and quality of life outcomes in men with newly diagnosed metastatic prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2020.058 | Characterising and Fingerprinting Biomarkers of Urolithiasis: A Case Control Study |
Prof. NG Chi Fai 吳志輝 |
| 2019.662 | The use of REZUM system in Chinese male patients with lower urinary tract symptom secondary to benign prostate enlargement |
Prof. NG Chi Fai 吳志輝 |
| 2019.211 | To establish a reproducible organoid culture model with human kidney cancer |
Prof. NG Chi Fai 吳志輝 |
| 2018.323 | Can transperineal prostate biopsy replace transrectal prostate biopsy? Hong Kong experience of the first 100 cases of transperineal prostate biopsy |
Prof. NG Chi Fai 吳志輝 |
| 2019.017 | To investigate the possible underlying causes for patient with nocturia in Hong Kong patients |
Prof. NG Chi Fai 吳志輝 |
| 2018.376 | To identify potential new urine markers for the screening of prostate cancer |
Prof. NG Chi Fai 吳志輝 |
| 2019.400 | A retrospective review of the association of baseline characteristics of male patients presented with lower urinary tract and long term clinical outcomes |
Prof. NG Chi Fai 吳志輝 |
| 2020.185 | To compare Spermine Risk Score and Prostate Health Index in diagnosing prostate cancer in Chinese patients |
Prof. NG Chi Fai 吳志輝 |
| 2019.378 | To identify potential new genetic marker for diagnosis of cystinuria. |
Prof. NG Chi Fai 吳志輝 |
| 2018.063 | To investigate the diagnostic accuracy of exosomal microRNA in predicting the aggressiveness of prostate cancer in Chinese patients |
Prof. NG Chi Fai 吳志輝 |
| 2010.474 | Short stay transurethral prostate surgery: A prospective randomized controlled trial comparing efficacy of bipolar transurethral resection/vaporization of prostate with monopolar transurethral resection | Prof Ng Chi Fai |
| 2014.214 | A longitudinal study on the outcome of male voiding dysfunction in Hong Kong Chinese Male | Prof. NG Chi Fai |
| 2013.536 | A Randomized, Double-Blind, Parallel-Group, Placebo- and Active- Controlled, Multi-center Study to Evaluate the Efficacy, Safety and Tolerability of Combinations of Solifenacin Succinate and Mirabegron Compared to Solifenacin Succinate and Mirabegron Monotherapy in the Treatment of Overactive Bladder | Prof. NG Chi Fai |
| 2010.494 | A prospective study to investigate the effect of different treatment protocols on renal injury during extracorporeal shockwave lithotripsy | Prof. Ng Chi Fai |
| 2012.105 | ADJUVANT AXITINIB TREATMENT OF RENAL CANCER: A RANDOMIZED DOUBLE-BLIND PHASE 3 STUDY OF ADJUVANT AXITINIB VS. PLACEBO IN SUBJECTS AT HIGH RISK OF RECURRENT RCC | Prof. NG Chi Fai |
| 2009.620 | Strategies To Prevent Renal Trauma | Prof. Ng Chi Fai |
| 2011.375 | A prospective randomized double-blinded placebo controlled study on the effects of shockwave therapy in patients suffered erectile dysfunction | Prof. Ng Chi Fai |
| 2010.577 | Prospective study of the effect of androgen deprivation therapy (ADT) in male patients suffered prostate cancer in Chinese Population | Prof. NG Chi Fai |
| 2010.125 | Study on Comparison of the clinical outcomes of extracorporeal shock wave lithotripsy for lower ureteric stone treated at different patient position | Prof. Ng Chi Fai |
| 2009.333 | The impact of 60 verse 120 shock wave per minute on treatment outcome, renal injury and patients | Prof. Ng Chi Fai |
| 2008.062 | A Prospective Study to Investigate the Effects of Different Shockwave Delivery Rates in Extracorporeal Shockwave Lithotripsy in Patients Suffer form Renal Calculi | Prof. Ng Chi Fai |
| 2010.465 | A Phase 3, Randomized, Double-Blind, Multicenter Trial Comparing Orteronel (TAK-700) Plus Prednisone With Placebo Plus Prednisone in Patients With Chemotherapy-Na_ve Metastatic Castration-Resistant Prostate Cancer | Professor Ng Chi Fai |
| 2008.324 | A Randomized, Open Label, Multi-Center Phase II Study to Compare Bevacizumab Plus RAD001 Versus Interferon Alfa-2a Plus Bevacizumab for the First-line Treatment of Patients with Metastatic Clear Cell Carcinoma of the Kidney | Prof Ng Chi Fai |
| 2010.507 | The role of weight reduction on the severity of lower urinary tract symptoms in obese male patients with benign prostatic hyperplasia. | Prof. Ng Chi Fai |
| 2013.494 | PROSPER: A Multinational, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer | Prof. NG Chi Fai |
| 2014.096 | A prospective study to investigate the effect of stepwise voltage escalation on treatment outcome in extracorporeal shockwave lithotripsy of renal calculi | Prof. Ng Chi Fai |
| 2014.090 | A Multicenter, Single-Arm, Open-Label, Post-Marketing Safety Study to Evaluate the Risk of Seizure Among Subjects with Metastatic Castration-Resistant Prostate Cancer (mCRPC)Treated with Enzalutamide Who Are at Potential Increased Risk of Seizure | Prof. NG Chi Fai |
| 2010.392 | A prospective randomized double-blinded placebo controlled study on the effects of adjuvant tamsulosin OCAS in the treatment outcome of patient receiving extracorporeal shock wave lithotripsy for renal calculi | Prof Ng Chi Fai |
| 2012.399 | Health Exhibition Health Check Survey | Prof. Ng Chi Fai |
| 2012.316 | The pattern of presentation of Chinese diagnosed with prostate cancer | Prof Ng Chi Fai |
| 2009.528 | A Phase 2B, Randomized, Double-blind, Placebo-Controlled, Dose Ranging Study Evaluating the Efficacy and Safety of Tanezumab for the Treatment of Moderate to Severe Pain Associated with Interstitial Cystitis / Painful Bladder Syndrome (IC/PBS) | Dr. Ng Chi Fai |
| 2013.493 | A Double-blind, Randomized, Placebo-Controlled Study Evaluating the Safety and Effectiveness of Cook MyoSite Incorporated AMDC in Female Patients with Stress Urinary Incontinence | Prof Ng Chi Fai |
| 2008.305 | Investigation of Endothelial Function and Oxidative Stress Biomarkers in Renal Arteries from Patients with Hypertension and Diabetes | Prof. Ng Chi Fai |
| 2010.152 | To Investigate the Effects of Male Patient Lower Urinary Tract Symptoms (LUTS) on Their Spouse - A Questionnaire Survey | Prof. Ng Chi Fai |
| 2011.373 | Tissue collection for prostate cancer (ICGC) | Prof. NG Chi Fai |
Page 189 of 289.